Endocrine gland-derived vascular endothelial growth factor induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands. Its expression is often complementary to the expression of VEGF, suggesting that these molecules function in a coordinated manner.
Caractéristiques techniques
| Marque | Invitrogen |
| Réf. B-LABO | BL-RE-167175 |
| Réf. fabricant | 30087880 |
| Numéro d’adhésion | P58294 |
|---|
| Plage de dosage | Lot-specific |
|---|
| Sensibilité du dosage | Lot-specific |
|---|
| Conjugué | HRP |
|---|
| Type de produit | ELISA Kit |
|---|
| À utiliser avec (équipement) | Colorimetric Microplate Reader |
|---|
| Identification génétique (Entrez) | 84432 |
|---|
| Symbole de gène(s) | PROK1 |
|---|
| Contenus des kits | This Human PROK1 ELISA Kit includes Capture Antibody, Detection Antibody, Protein Standard, and HRP-conjugate. The HRP-conjugate is packaged separately. |
|---|
| Marqueur ou colorant | HRP |
|---|
| Quantité | 10 x 96 Tests |
|---|
| État réglementaire | RUO |
|---|
| Conditions de stockage | Refer to product documentation for component specific storage temperature. |
|---|
| Cible | Human EG-VEGF/PROK1 ELISA Development Kit (ABTS) |
|---|
| Heure du test | 1 hr 45 min |
|---|
| Durée totale du dosage | 24 hr 30 min |
Une question, une configuration particulière ?
Contactez-nous pour un devis.